Home › Post-COVID Conditions (Long COVID) › New Jersey
Post-COVID Conditions (Long COVID) clinical trials in New Jersey
3 studies for Post-COVID Conditions (Long COVID) are looking for participants at sites in New Jersey.
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- Saint Michael's Medical Center ( Site 3808), Newark
- Holy Name Medical Center ( Site 3807), Teaneck
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT06667700A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Holy Name Medical Center, Teaneck
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07013474Care for Veterans Post-COVID-19
- East Orange Campus of the VA New Jersey Health Care System, East Orange, NJ, East Orange
Recruiting
All ages · All sexes · Updated Dec 24, 2025 · NCT05787379From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.